Telomir Pharmaceuticals, Inc.'s total assets for Q1 2025 were $491.19K, a decrease of -62.90% from the previous quarter. TELO total liabilities were $652.29K for the fiscal quarter, a -4.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.